Cane Berrong

2024 Fantasy Outlook
There was no outlook written for Cane Berrong in 2024. Check out the latest news below for more on his current fantasy value.
Commits to Coastal Carolina
Not Injury Related
January 19, 2023
Berrong announced Thursday via his personal Twitter page that he will transfer to play at Coastal Carolina.
ANALYSIS
Berrong will hope to ignite his collegiate career with the Chanticleers after failing to catch a pass during his tenure at Notre Dame. He'll have three years of eligibility remaining.
Read More News
College Football Stats
Loading CFB Stats...
2024
2022
2021
2024 CFB Game Log
calculator icon
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Loading Game Log...
2022 CFB Game Log
calculator icon
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
2021 CFB Game Log
calculator icon
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
Chanticleers Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Cane Berrong See More
2023 Sun Belt Conference Preview: Sleepers, Busts and All-Conference Teams
August 20, 2023
The Sun Belt features a number of intriguing running back options, but none more so than Marshall's Rasheen Ali. See who else made the cut on our sleeper, bust and all-conference lists.
More Fantasy News
Heading to transfer portal
Not Injury Related
December 12, 2022
Berrong entered the transfer portal Monday, per Rivals.com.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Returns to action
August 25, 2022
Berrong (knee) is active and practicing for Notre Dame ahead of their season-opener against Ohio State, Mike Berardino of USA Today reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Tears ACL, done for season
October 15, 2021
Berrong will miss the remainder of the season due to a torn ACL, Rivals.com reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.